BioCryst Pharmaceuticals ↗
Biotechnology: Biological Products (No Diagnostic Substances) company
Key Metrics of BioCryst Pharmaceuticals
Revenue$331M▲ 22.4% YoYFY 2023
Operating income−$104M▲ 30.1% YoY
Net profit−$227M▲ 8.3% YoY
Shareholders' equity−$456M
Market cap$2.0BBCRX · $7.88
Competitors10identified
About BioCryst Pharmaceuticals
Sectors
Company details
- Website
- biocryst.com
- Founded
- 1994
- Listed
- Nasdaq: BCRX (since 1994)
Operational Areas of BioCryst Pharmaceuticals
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Legal nameBioCryst Pharmaceuticals Inc.
TickerBCRX
ExchangeNasdaq
CountryUnited States
SEC CIK0000882796
Listed since1994
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Websitehttp://www.biocryst.com
US market & SEC filings
BCRX · Nasdaq · SEC CIK 0000882796
Last price · 27 Oct 2026
$7.88
+3.01%
Market cap$2.0B
P/E—On FY 2023 diluted EPS
Volume4,380,510
SectorHealth CareBiotechnology: Biological Products (No Diagnostic Substances)
Country · IPOUnited StatesListed 1994
BCRX share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeDurham
GSTIN—
Email—
Websitehttp://www.biocryst.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of BioCryst Pharmaceuticals
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | bms.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | marriott.com.cn | — | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
pharmaceutical industry
Filings
No filings on record yet.